
AMD is one of the leading causes of vision loss in adults over 60. It occurs when the macula—the central area of the retina responsible for detailed vision—degenerates due to oxidative stress, inflammation, and mitochondrial decline.
Retinal cells are among the most energy-demanding in the body. As mitochondria weaken with age, energy production falls and oxidative damage increases. PBM (Photobiomodulation) uses red (630–660 nm) and near-infrared (810–850 nm) wavelengths to restore mitochondrial function.
Recent clinical trials have demonstrated that PBM can significantly improve visual acuity and color contrast in early-stage AMD. While not a cure, it’s a safe adjunct to standard ophthalmologic care.
PBM also reduces systemic inflammation, which plays a role in vascular and ocular degeneration. Many of our patients undergoing red-light bed sessions for joint or skin health notice clearer vision and less eye fatigue as an unexpected bonus.
At Sheen Vein, we combine red-light therapy with nutritional support—such as lutein, zeaxanthin, omega-3s, and CoQ10—and lifestyle strategies that reduce oxidative burden.
Our red-light protocols are eye-safe, carefully dosed, and supervised by clinicians familiar with mitochondrial and vascular medicine.
The future of vision care is regenerative. By supporting cellular energy and microcirculation, PBM may help preserve sight and independence for years to come.
Internal links: